BIO-ANALYTICAL LABORATORY EXPERIENCE

mass spectrometers
0
Over 200 validated methods
0
Over 20 dedicted laboratory scientists
0
robotic systems for automatic sample preparation
0
Over 100,000 samples analysed per year
0

3SPHARMA

Equipment:

  • 4 mass spectrometers coupled with: HPLC & CE (capilary electrophoresis)
  • One ICP MS
  • Robotic systems for samples preparation (4 Hamilton robotics), 1 Extrahera, 1 Gilson

        More than 200 validated bio-analytical methods.

GLP CERTIFIED since 2003

  • Inspected by french, dutch, austrian, german, romanian, island and danish (on behalf of ema) authorities over 12 european inspections till now
  • 2 FDA INSPECTIONS, one in Nov. 2013 and one in April 2023; both concluded
    without a 483 Form !

BIO-ANALYTICAL

EXPERIENCE:

Our senior researchers have more than 25 years of experience in bio-analytical and mass spectrometry, working with:

  • Small molecules
  • Peptides
  • Large molecules
  • Chiral compounds

COMPLEX SAMPLES PREPARATION

Over 100.000 samples analyzed per year!

  • Solid and liquid extraction
  • Derivatization
  • Chemical or enzymatic digestion
  • In vitro metabolism with microsomes

Good Laboratory Practice

certified since 2003

Our bio-analytical laboratory was repeatedly inspected by EMA and by various National EU Authorities as well as by US-FDA

EMA Inspections were carried out in September 2014 and June 2024 !

Other EU Authorities conducted inspections: Austrian, Dutch, French, German, and Romanian authorities  (over 14 European inspections to date)

US-FDA Inspections were carried out first in 2013 and the most recent in April 2023 ! 

All US-FDA inspections concluded without a 483 Form

Our bio-analytical laboratory was repeatedly inspected by EMA and by various National EU Authorities as well as by US-FDA

EMA Inspections were carried out in September 2014 and June 2024 !

Other EU Authorities conducted inspections: Austrian, Dutch, French, German, and Romanian authorities (over 14 European inspections to date)

US-FDA Inspections were carried out first in 2013 and the most recent in April 2023!

All US-FDA inspections concluded without a 483 Form